Technical Data
E9005-08J
Exodus 2, Recombinant, Human (Exodus-2, 6Ckine, Beta Chemokine Exodus-2, Chemokine (C-C Motif) Ligand 21, CCL21, CKb9, ECL, MGC34555, Secondary Lymphoid Tissue Chemokine, SLC, Small Inducible Cytokine A21, SCYA21, TCA4)
20ug
|
Technical Data |
|
E9005-08J |
Exodus 2, Recombinant, Human (Exodus-2, 6Ckine, Beta Chemokine Exodus-2, Chemokine (C-C Motif) Ligand 21, CCL21, CKb9, ECL, MGC34555, Secondary Lymphoid Tissue Chemokine, SLC, Small Inducible Cytokine A21, SCYA21, TCA4) |
20ug |
| Growth Factors, Cytokines | Storage: -20°CShipping: Blue Ice |
|
Source: Recombinant corresponding to human EXODUS 2 prepared from E.coli, a member of the CC chemokine family which inhibits haemopoiesis and stimulates chemotaxis. Molecular Weight: ~12.2kD (111aa sequence) Endotoxin: 0.1 ng/mg Applications: Suitable for use in Functional Assays. Other applications not tested. Recommended Dilution: Optimal dilutions to be determined by the researcher. Storage and Stability: Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with 20ul sterile dH2O. Aliquot and store at -20°C. Reconstituted product is stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. |
Source: Human Purity: Purified: ~99% (SDS PAGE). Form: Supplied as a lyophilized powder. Preservative free. Reconstitute with 20ul sterile dH2O. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
|
|
||